Advertisement

Indian Journal of Surgical Oncology

, Volume 9, Issue 4, pp 568–575 | Cite as

Prevalence and Impact of Human Papillomavirus on Head and Neck Cancers: Review of Indian Studies

  • Deepa NairEmail author
  • Manish Mair
  • Arjun Singh
  • Anil D’Cruz
Review Article
  • 56 Downloads

Abstract

Human papillomavirus (HPV) is an important emerging etiology for head and neck cancers (HNCs) worldwide. Considering its impact on prognosis, it is important to understand the true prevalence of HPV-associated HNCs in India. This article reviews the prevalence of HPV-related HNCs across various studies in India where the population is predominantly tobacco users, and studies its outcomes with respect to HPV.

Keywords

Human papillomavirus Head and neck cancers Prevalence India Prognosis 

References

  1. 1.
    IARC Monographs- Monographs available in PDF format. http://monographs.iarc.fr/ENG/Monographs/vol90/index.php. Accessed 27 Feb 2018
  2. 2.
    Combes J-D, Franceschi S (2014) Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 50:370–379.  https://doi.org/10.1016/j.oraloncology.2013.11.004 CrossRefPubMedGoogle Scholar
  3. 3.
    Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol Off J Am Soc Clin Oncol 29:4294–4301.  https://doi.org/10.1200/JCO.2011.36.4596 CrossRefGoogle Scholar
  4. 4.
    Mehanna H, Beech T, Nicholson T, el-Hariry I, McConkey C, Paleri V, Roberts S (2013) Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region. Head Neck 35:747–755.  https://doi.org/10.1002/hed.22015 CrossRefPubMedGoogle Scholar
  5. 5.
    Bharti AH, Chotaliya K, Marfatia YS (2013) An update on oral human papillomavirus infection. Indian J Sex Transm Dis 34:77–82.  https://doi.org/10.4103/0253-7184.120533 CrossRefGoogle Scholar
  6. 6.
    Balaram P, Nalinakumari KR, Abraham E et al (1995) Human papillomaviruses in 91 oral cancers from Indian betel quid chewers--high prevalence and multiplicity of infections. Int J Cancer 61:450–454CrossRefGoogle Scholar
  7. 7.
    D’Costa J, Saranath D, Dedhia P et al (1998) Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 34:413–420CrossRefGoogle Scholar
  8. 8.
    Jacob SE, Sreevidya S, Chacko E, Pillai MR (2002) Cellular manifestations of human papillomavirus infection in laryngeal tissues. J Surg Oncol 79:142–150CrossRefGoogle Scholar
  9. 9.
    Nagpal JK, Patnaik S, Das BR (2002) Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 97:649–653CrossRefGoogle Scholar
  10. 10.
    Koppikar P, deVilliers EM, Mulherkar R (2005) Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer 113:946–950CrossRefGoogle Scholar
  11. 11.
    Mitra S, Banerjee S, Misra C et al (2007) Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population. J Clin Pathol 60(9):1040–1047.  https://doi.org/10.1136/jcp.2005.034835. CrossRefPubMedGoogle Scholar
  12. 12.
    Ghosh S, Ghosh A, Maiti GP, Alam N, Roy A, Roy B, Roychoudhury S, Panda CK (2008) Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: Correlation with progression and prognosis. Int J Cancer 123(11):2594–2604.  https://doi.org/10.1002/ijc.23834 CrossRefPubMedGoogle Scholar
  13. 13.
    Gheit T, Vaccarella S, Schmitt M, Pawlita M, Franceschi S, Sankaranarayanan R, Sylla BS, Tommasino M, Gangane N (2009) Prevalence of human papillomavirus types in cervical and oral cancers in Central India. Vaccine 27:636–639.  https://doi.org/10.1016/j.vaccine.2008.11.041 CrossRefPubMedGoogle Scholar
  14. 14.
    Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Singh M, Singh M (2010) Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma. Virol J 7:253.  https://doi.org/10.1186/1743-422X-7-253 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Jalouli J, Ibrahim SO, Mehrotra R, Jalouli MM, Sapkota D, Larsson PA, Hirsch JM (2010) Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol 130(11):1306–1311.  https://doi.org/10.3109/00016481003782041 CrossRefPubMedGoogle Scholar
  16. 16.
    Barwad A, Sood S, Gupta N, Rajwanshi A, Panda N, Srinivasan R (2012) Human papilloma virus associated head and neck cancer: A PCR based study. Diagn Cytopathol 40(10):893–897.  https://doi.org/10.1002/dc.21667 CrossRefPubMedGoogle Scholar
  17. 17.
    Kulkarni SS, Kulkarni SS, Vastrad PP, Kulkarni BB, Markande AR, Kadakol GS, Hiremath SV, Kaliwal S, Patil BR, Gai PB (2011) Prevalence and distribution of high risk human papillomavirus (HPV) Types 16 and 18 in Carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India. Asian Pac J Cancer Prev 12(3):645–648PubMedGoogle Scholar
  18. 18.
    Mondal R, Ghosh SK, Choudhury JH, Seram A, Sinha K, Hussain M, Laskar RS, Rabha B, Dey P, Ganguli S, Nathchoudhury M, Talukdar FR, Chaudhuri B, Dhar B (2013) Mitochondrial DNA copy number and risk of oral cancer: a report from Northeast India. PLoS One 8(3):e57771.  https://doi.org/10.1371/journal.pone.0057771 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Bahl A, Kumar P, Dar L, Mohanti BK, Sharma A, Thakar A, Karthikeyan V, Sikka K, Singh C, Poo K, Lodha J (2014) Prevalence and trends of human papillomavirus in oropharyngeal cancer in a predominantly north Indian population. Head Neck 36(4):505–510.  https://doi.org/10.1002/hed.23317 CrossRefPubMedGoogle Scholar
  20. 20.
    Ramshankar V, Soundara VT, Shyamsundar V, Ramani P, Krishnamurthy A (2014) Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Asian Pac J Cancer Prev APJCP 15:8351–8359CrossRefGoogle Scholar
  21. 21.
    Singh V, Husain N, Akhtar N, Kumar V, Tewari S, Mishra S, Misra S, Khan MY (2015) Do Human Papilloma Viruses Play Any Role in Oral Squamous Cell Carcinoma in North Indians? Asian Pac J Cancer Prev 16(16):7077–7084CrossRefGoogle Scholar
  22. 22.
    Kumar R, Rai AK, Das D, Das R, Kumar RS, Sarma A, Sharma S, Kataki AC, Ramteke A (2015) Alcohol and tobacco increases risk of high risk HPV infection in head and neck cancer patients: study from north-east region of India. PLoS One 10:e0140700.  https://doi.org/10.1371/journal.pone.0140700 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Jitani AK, Raphael V, Mishra J et al (2015) Analysis of human papilloma virus 16/18 DNA and its correlation with p16 expression in oral cavity squamous cell carcinoma in North-Eastern India: a chromogenic in-situ hybridization based study. J Clin Diagn Res 9:EC04-07.  https://doi.org/10.7860/JCDR/2015/13022.6285 CrossRefGoogle Scholar
  24. 24.
    Parshad S, Nandi S, Marwah N et al (2015) Human papillomavirus 16 and 18 in squamous cell carcinoma of oral cavity and sexual practices: A pilot study at a Tertiary Care Hospital of North India. Natl J Maxillofac Surg 6(2):185–189.  https://doi.org/10.4103/0975-5950.183857 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Ralli M, Singh S, Yadav SPS, Sharma N, Verma R, Sen R (2016) Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma. J Cancer Res Ther 12:232–237.  https://doi.org/10.4103/0973-1482.151447 CrossRefPubMedGoogle Scholar
  26. 26.
    Singh AK, Kushwaha JK, Anand A, Sonkar AA, Husain N, Srivastava K, Singh S (2016) Human papilloma virus in oral cavity cancer and relation to change in quality of life following treatment-a pilot study from northern India. Indian J Surg Oncol 7:386–391.  https://doi.org/10.1007/s13193-016-0559-4 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Murthy V, Swain M, Teni T, Pawar S, Kalkar P, Patil A, Chande A, Ghonge S, Laskar SG, Gupta T, Budrukkar A, Agrawal J (2016) Human papillomavirus/p16 positive head and neck cancer in India: prevalence, clinical impact, and influence of tobacco use. Indian J Cancer 53:387–393.  https://doi.org/10.4103/0019-509X.200668 CrossRefPubMedGoogle Scholar
  28. 28.
    Verma G, Vishnoi K, Tyagi A et al (2017) Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers. Cancer Med 6(3):591–604.  https://doi.org/10.1002/cam4.983 CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Gheit T, Anantharaman D, Holzinger D, Alemany L, Tous S, Lucas E, Prabhu PR, Pawlita M, Ridder R, Rehm S, Bogers J, Maffini F, Chiocca S, Lloveras B, Kumar RV, Somanathan T, de Sanjosé S, Castellsagué X, Arbyn M, Brennan P, Sankaranarayanan R, Pillai MR, Gangane N, Tommasino M, HPV-AHEAD study group (2017) Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India. Int J Cancer 141(1):143–151.  https://doi.org/10.1002/ijc.30712. CrossRefPubMedGoogle Scholar
  30. 30.
    Yete S, D’Souza W, Saranath D (2017) High-risk human papillomavirus in oral cancer: clinical implications. Oncology 94:133–141.  https://doi.org/10.1159/000485322 CrossRefPubMedGoogle Scholar
  31. 31.
    Elango KJ, Suresh A, Erode EM, Subhadradevi L, Ravindran HK, Iyer SK, Iyer SK, Kuriakose MA (2011) Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev APJCP 12:889–896PubMedGoogle Scholar
  32. 32.
    Sannigrahi MK, Singh V, Sharma R, Panda NK, Radotra BD, Khullar M (2016) Detection of active human papilloma virus-16 in head and neck cancers of Asian North Indian patients. Oral Dis 22:62–68.  https://doi.org/10.1111/odi.12382 CrossRefPubMedGoogle Scholar
  33. 33.
    Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH, Ang KK (2012) Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol Off J Am Soc Clin Oncol 30:2102–2111.  https://doi.org/10.1200/JCO.2011.38.4099 CrossRefGoogle Scholar
  34. 34.
    Herrero R, Castellsagué X, Pawlita M et al (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95:1772–1783CrossRefGoogle Scholar
  35. 35.
    Würdemann N, Wagner S, Sharma SJ, Prigge ES, Reuschenbach M, Gattenlöhner S, Klussmann JP, Wittekindt C (2017) Prognostic impact of AJCC/UICC 8th edition new staging rules in oropharyngeal squamous cell carcinoma. Front Oncol 7.  https://doi.org/10.3389/fonc.2017.00129
  36. 36.
    Marur S, D’Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781–789.  https://doi.org/10.1016/S1470-2045(10)70017-6 CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Ang KK, Sturgis EM (2012) Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol 22:128–142.  https://doi.org/10.1016/j.semradonc.2011.12.004 CrossRefPubMedGoogle Scholar
  38. 38.
    Gillison ML (2004) Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31:744–754CrossRefGoogle Scholar
  39. 39.
    O’Sullivan B, Huang SH, Su J et al (2016) Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 17:440–451.  https://doi.org/10.1016/S1470-2045(15)00560-4 CrossRefPubMedGoogle Scholar
  40. 40.
    Haughey BH, Sinha P, Kallogjeri D, Goldberg RL, Lewis JS Jr, Piccirillo JF, Jackson RS, Moore EJ, Brandwein-Gensler M, Magnuson SJ, Carroll WR, Jones TM, Wilkie MD, Lau A, Upile NS, Sheard J, Lancaster J, Tandon S, Robinson M, Husband D, Ganly I, Shah JP, Brizel DM, O’Sullivan B, Ridge JA, Lydiatt WM (2016) Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral Oncol 62:11–19.  https://doi.org/10.1016/j.oraloncology.2016.09.004 CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Sharma A, Méndez E, Yueh B, Lohavanichbutr P, Houck J, Doody DR, Futran ND, Upton MP, Schwartz SM, Chen C (2012) Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories. Otolaryngol Head Neck Surg 146:739–745.  https://doi.org/10.1177/0194599811434707 CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Spinato G, Stellin M, Azzarello G, Bonazza D, Zanconati F, Politi D, Cocuzza S, di Mauro P, Ausoni S, Tonoli G, Costantini G, Maiolino L, Spinato R, da Mosto MC, Baboci L, del Mistro A, Serra A, Tirelli G (2017) Multicenter research into the quality of life of patients with advanced oropharyngeal carcinoma with long-term survival associated with human papilloma virus. Oncol Lett 14:185–193.  https://doi.org/10.3892/ol.2017.6152 CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Wirth LJ (2016) Cetuximab in human papillomavirus–positive oropharynx carcinoma. J Clin Oncol 34:1289–1291.  https://doi.org/10.1200/JCO.2015.65.1414 CrossRefPubMedGoogle Scholar
  44. 44.
    Marur S, Li S, Cmelak AJ, Gillison ML, Zhao WJ, Ferris RL, Westra WH, Gilbert J, Bauman JE, Wagner LI, Trevarthen DR, Balkrishna J, Murphy BA, Agrawal N, Colevas AD, Chung CH, Burtness B (2016) E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx— ECOG-ACRIN Cancer Research Group. J Clin Oncol 35:490–497.  https://doi.org/10.1200/JCO.2016.68.3300 CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Mirghani H, Blanchard P (2018) Treatment de-escalation for HPV-driven oropharyngeal cancer: where do we stand? Clin Transl Radiat Oncol 8:4–11.  https://doi.org/10.1016/j.ctro.2017.10.005 CrossRefPubMedGoogle Scholar
  46. 46.
    Gillison ML, Chaturvedi AK, Lowy DR (2008) HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113:3036–3046.  https://doi.org/10.1002/cncr.23764 CrossRefPubMedGoogle Scholar

Copyright information

© Indian Association of Surgical Oncology 2018

Authors and Affiliations

  • Deepa Nair
    • 1
    Email author
  • Manish Mair
    • 1
  • Arjun Singh
    • 1
  • Anil D’Cruz
    • 1
  1. 1.Head and Neck Surgical OncologyTata Memorial HospitalMumbaiIndia

Personalised recommendations